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Introduction
The prevalence of diabetes mellitus in adult is increasing
worldwide; from 4.0% (135 million) in 1995, it is
estimated to rise to 5.4% (300 million) by the year 2025
and the main area of this increase will occur in
developing countries'. In Malaysia, the National Health
and Morbidity Survey II (NHMS II) conducted in 1996
revealed that 8.3% of the population had diabetes
mellitus'. This figure was alarming when compared to
the estimated worldwide prevalence.
Recently, the Diabcare Asia Study3 that involved six
Asian countries showed that only about 18% of diabetic
patients had good glycaemic control based on fasting
glucose or glycosylated haemoglobin (HbA1c) level and
54% had a total cholesterol level of > 5.2 mmolli. In a
local study, only 9% of the diabetic patients achieved
good glycaemic control and 65% had undesirable weight
gain while on treatment'.
Type 2 diabetes mellitus is an independent risk factor for
macrovascular disease, and its common coexisting
conditions such as hypertension, obesity and
dyslipidaemia are modifiable risk factors for
cardiovascular diseases'. The cardiovascular mortality
for a diabetic patient without a previous myocardial
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infarction was the same as that for a non-diabetic patient
with myocardial infarction6•
National practice guidelines on management of diabetes
mellitus7 and hypertensions were available in all health
centres in Melaka Tengah District to help primary care
doctors to better manage their patients with diabetes
mellitus. The adherence and implementation of the
guidelines is important to improve disease outcome and
prevention of cardiovascular diseases among diabetic
patients. Hence, the purpose of this study was to
examine whether the management of diabetes mellitus
and its associated cardiovascular risk factors among
diabetic patients at health centres conforms to current
guidelines.
Materials and Methods
This was a cross sectional study conducted in Melaka
Tengah District, one of the three districts in Melaka
state, from August to October 2003. All 11 government
health centres providing primary healthcare in the
district were included in this study. There are one or
two primary healthcare doctors working in each health
centre and all of them have basic medical degrees.
A systematic sampling 0:5) was used for registered
diabetic patients who came for follow up during this
period of study. The inclusion criteria are Malaysian
citizens and the patients had been followed up for
diabetes mellitus in the health centre for at least 12
months. Patients who· had newly diagnosed diabetes
mellitus, had defaulted treatment for more than six
months, were critically ill or had mental health or
difficulty in communication were excluded.
After the doctor had interviewed and examined the
selected patient, trained medical assistants of the
respective health centres gathered data from the
patient's medical record into a specially designed form.
Data collected included demographic characteristics,
duration of diabetes mellitus, current smoking habit,
self reported exercise, latest blood pressure (BP)
measurement, body mass index (BM!), fasting lipid
profile (FLP), glycosylated haemoglobin levels
(HbAlc), results of microalbuminuria, types of
antidiabetic and antihypertensive drugs prescribed.
Patients with Type 2 diabetic mellitus in this study were
defined according to the criteria set by the Malaysian
practice guidelines for Type 2 diabetes mellitus7 or if
the patients were known to have diabetes mellitus as
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evidenced from referral letters to the health centres by
general practitioners or hospital specialists.
Hypertension was taken as a systolic BP of 140mm Hg
or greater and/or a diastolic BP of 90 mmHg or greater
or patients with known hypertension currently on
antihypertensive medications. Standard mercury
sphygmomanometer with appropriately sized cuff was
used to measure patient's BP by a doctor using the right
arm of the patient who had been rested for at least 5
minutes and seated with the arm supported at heart
level. An average of two BP readings taken 2 minutes
apart was used and the reading was rounded to the
nearest 2 mmHg. All the primary care doctors were
briefed about the methodology prior to the
commencement of the study.
BMI was calculated from patient'S height and weight
using standard measurement equipments in the health
centres. Blood and urine samples were collected
during the study period for assessment of FLP, HbAlc,
and microalbuminuria. Fasting lipid profile (total
cholesterol, low-denSity lipoprotein cholesterol [LDL-C],
high-density lipoprotein cholesterol [HDL-C],
triglycerides) was assessed using Hitachi Chemistry
Analyzer 902 whereas HbAlc was assessed
quantitatively using DCA 2000 Analyzer based on latex
immunoagglutination inhibition. The HbAlc has been
recommended to be maintained below 7% and HbAlc
level of more than 8% indicates poor controlS.
Microalbuminuria was semiquantitatively detected by
using CLINITEK® microalbumin reagent strips and
CLINITEK® 50 urine analyzer. Patient would be
considered to have microalbuminuria if they have 2
separate positive results taken two weeks apart after
excluding other causes such as urinary tract infection.
Albumin is normally present in the urine at a
concentration of less than 30 mg albumin!g creatinine
(3.4 mg albumin/mmol creatinine). Microalbuminuria
is indicated at a ratio result of 30 - 300 mglg (3.4 ~ 33.9
mg/mmol) and clinical albuminuria
(macroalbuminuria) at a ratio result of > 300 mg/g (>
33.9 mglmmol).
SPSS version 11 was used for data analysis. The
associations between ethnicity and mean HbAlc, LDL-
C and BMI were analyzed with One-way Analysis of
Variance (ANOVA). The associations between ethnicity
and the presence of microalbuminuria, current smoker
status were analyzed using Chi-squared test. P value of
less than 0.05 was chosen for interpretation of statistical
significance.
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Results
A total of 517 patients with diabetes mellitus were
recruited. All of them had tYpe 2 diabetes mellitus with
four of them on adjunctive insulin regime. Three
hundred and thirteen (60.5%) patients were female.
The mean age of the patients was 57.9 ± 10.5 years
(range 24 to 91 years). The mean duration of diabetes
mellitus was 7.2 years ± 6.0 years (range 1 to 31 years).
There were 285 (55.1%) Malay, 190 (36.8%) Chinese
and 41 (7.9%) Indian in this study. This distribution of
ethnic groups was fairly representative of the total
5,256 registered diabetic patients in Melaka Tengah
District in year 2003 where there were 53.6% Malay,
36.0% Chinese and 9.0% Indian9•
The glycaemic control of the patients was poor. The
mean HbA1c level was 8.5% (SD = 1.8%, range 4.6% to
13.3%). Two hundred and seventy seven (53.6%)
patients had HbA1c > 8%, 151 patients (29.2%) had
HbA1c between 7 - 8% and 89 (17.2%) had HbA1c
<7%. Indians had the highest mean HbA1c followed
by Malay and Chinese but there was no significant
difference shown. (see Table I)
Of the patients with HbA1c > 8%, about 47.6% of them
were prescribed monotherapy (68.3% with
glibenclamide and 27.3% with metformin).
Approximately 69% of the poorly controlled group had
BMI of 30 kg/m' and above but they were prescribed
glibenclamide only. The most common oral
hypoglycaemic agent used was glibenclamide (76.8%)
followed by metformin (61.5%), gliclazide (6.0%),
acarbose (2.7%) and chlorpropamide (1.5%).
About a quarter of the patients were found to have
microalbuminuria, being highest in the Chinese
followed by Malay and Indian but there was no
significant association shown. (see Table I)
In this study, 350 (67.7%) patients had hypertension
(2:140/90 mmHg). Based on the national clinical
practice guidelines on the management of hypertension8,
only 11(3.1%) of .them had achieved target blood
pressure of < 130/80 mmHg. For those who did not
achieve target BP, 134 (39.5%) of them were not on any
anti-hypertensive drugs and the average number of
antihypertensive medications used in this group of
patients was 1.4 (Figure 1). Sixty four (18.3%) diabetic
hypertensive, regardless of albuminuria status, were
prescribed ACE inhibitors (captopril and enalapril) and
0.3% was given ARBs (losartan).
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The mean low-density lipoprotein cholesterol (LDL-C)
of patients with diabetes mellitus was 3.4 ± 1.1mmol/l
(range 0.8 to 8.4 mmol/l). The LDL-C levels were not
significantly different among the different ethnic
groups. (see Table I) Three hundred and twenty five
patients (62.9%) had LDL-C level greater than 2.6
mmol/l but only 35 (6.8%) of them were prescribed
lipid-lowering agents. The agents used were lovastatin
(81.8%) and gemfibrozil (18.2%).
Anti-platelet agent such as aspirin was prescribed in
only 40 (8.2%) patients with age above 40 years
(n=490). In those with concomitant hypertension
(n=350), only 19 (5.4%) were prescribed aspirin.
Eighty (16%) patients were current smokers and 89% of
them were males. No significant difference was found
between ethnic groups and smoking habit. (see Table
I) The mean duration of smoking was 24.1 ± 13.7 years,
(range 1 to 60 years) with an average of 16 ± 12
cigarettes, (range 2 to 80 cigarettes) smoked per day.
About 274 (53%) patients did not do any exercise.
Taking a walk was the most common form of reported
exercise (33.9%) among those who did. The average
number of exercise per week was 4.6 ± 2.1, (range 1 to
7) with a mean duration of 33.9 minutes for each
occasion (SD=20.6 minutes, range 5 to 120 minutes).
The mean BMI was 26.8 ± 4.7 kg/m', (range 14.7 to
44.9 kg/m') with nearly two-thirds of them overweight
or obese. (see Figure 2) The BMI is significantly higher
in the Malays followed by the Indians and the Chinese.
(p< 0.0001, see Table I)
Discussion
Over half of the diabetic patients at the health centres in
Melaka Tengah District had poor glycaemic control
(HbA1c > '8). This could be attributed to improper use
of oral hypoglycaemic agents by the doctors as nearly
half of the diabetics were on monotherapy.
Combination therapy may be needed in these patients to
achieve target glycaemic goaF. In addition, metformin
should be the agent of choice in obese diabetic patients
as glibenclamide increases appetite and leads to weight
gain7• However, instead of metformin, nearly three
quarter of the poorly controlled group of patients with
BMI 30 kg/m' and above in this study were prescribed
glibenclamide alone.
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Table I: Summary of CVD risk factors in diHerent ethnic groups
Malay Chinese Indian All patients Pvalue
Mean HbA1c (%) 8.6 8.3 8.7 8.5 0.1
Mean lDl-C (mmol/I) 3.402 3.404 3.287 3.400 0.9
Microalbuminuria (%) 21.7 24.7 19.5 24.0 0.9
C;urrent smoker (%) 16.1 15.3 12.2 16.0 0.9
Mean BMI (kQ/m2) 27.6 27.2 25.6 26.8 P<O.OOOl
18.6%
Two
3.0%
Three -
0.3%
- Four
Healthy weigt
176(34.0%)
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Fig. 1: Number of antihypertensive
prescribed in diabetic
hypertension (n:350) ,
agents
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Fig. 2: BMI among patients with diabetes
mellitus (n:517)
Although the association between ethnic groups and
HbAlc and microalbuminuria was not significantly
different, Indians appeared to have the highest HbAlc
but the lowest prevalence of microalbuminuria whereas
Chinese had the highest prevalence of microalbuminuria
but lowest in the level of HbAlc. These findings were
similarly observed in a study conducted in Singapore
recentlylO. The reasons need exploration in future. More
aggressive glycaemic control is needed especially among
the Indians for prevention of future cardiovascular
diseases (CVD). In addition, early detection of
microalbuminuria is also important, as it is an
independent predictor of progressive renal disease,ll as
well as a well-established marker of increased CVD risk
in type 2 diabetes mellitus".
The prevalence of hypertension among patients with
diabetes mellitus in this study was 67.7% and this result
was comparable with studies elsewhere (20 to 60%)13.
People with .coexisting diabetes mellitus and
hypertension have approximately twice the risk of
getting cardiovascular diseases 13 and control of blood
pressure is effective in reducing cardiovascular events
and mortality14. In this study, majority of the patients did
not achieve the target blood pressure of less than 130/80
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mmHg. This poor control of hypertension could be due
to several factors: the doctors were not aggressive
enough in their management of hypertension. The
average number of antihypertensive drugs used was
only 1.4 while clinical trials had demonstrated that more
than 65% of the people with diabetes and hypertension
would require two or more antihypertensive medications
to achieve the target blood pressure of 130/80 mmHg'5•
In addition, the use of ACE inhibitors and ARBs were
low among the diabetics with hypertension. Both ACE
inhibitors and ARBs have been shown to reduce the
incidence of cardiovascular diseases and stroke in
patients with diabetes mellitus as well as affecting the
progression of diabetic nephropathy and reduce
albuminuria. ARBs have been shown to reduce the
progression to macroalbuminuria as well'6,17. Although
the availability of these medications especially ARBs may
be an issue in the health centres, greater awareness of
the benefits of these medications and optimal control of
BP in diabetic patients need to be addressed.
With regard to lipid and anti-platelet therapies,
stratification of risk factors for coronary heart disease
(CHD) in type 2 diabetes mellitus shows that LDL-C is
the best predictor of CHD'8 and lowering of LDL-C to .:s
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2.6 mmol/l has been recommended as the primary goal
of therapy for adult19. On the other hand, aspirin has
been recommended for primary20 and secondary
prevention21 of cardiovascular events in diabetics and
non-diabetic individuals. Despite this, very few diabetics
with LDL-C greater than 2.6 mmoVl and who are above
40 years old 8 in this study were prescribed lipid-lowering
agents and aspirin.
We find a lower prevalence of current smoker among
patients with diabetes mellitus than that was found in the
NHMS II2 (16% vs 24.8%). This is encouraging as
smoking significantly enhances the risk of cardiovascular
diseases, contributing to premature morbidity and
mortality in patients with diabetes mellitus22. Studies had
shown that the prevalence of smoking may be
equivalent among individuals with or without diabetes
mellitus and only half of them were advised to quit
smoking by their health care providers". Therefore it is
important to assess the smoking status for all diabetics as
part of routine care and quit smoking counselling and
pharmacological help should be provided.
Regular exercise improves blood glucose control, reduce
cardiovascular risk factors, contribute to weight loss, and
improve individual well-being24'26. A lack of exercise
was documented in over half of the patients with
diabetes mellitus in this study. A regular physical activity
program, adjusted to the presence of complications
should be encouraged in all patients with diabetes.
Obesity is a common coexisting problem in patients with
diabetes mellitus. It is estimated to occur in about 60%
of type 2 diabetics in western countries27.28 • We found
38.9% and about a quarter of the diabetics were
overweight and obese and these figure were much
higher than that among the general population of
Malaysia in 1996 in the NHMS 2 where 16.6% were
found to be overweight and 4.4% obese'. Excess
weight is. associated with an increased incidence. of
cardiovascular diseases, type 2 diabetes mellitus,
hypertension, stroke, dyslipidaemia, osteoarthritis and
certain cancers'9. Therefore, obese patients with
diabetes mellitus especially the Malays who had the
highest EMI should be reinforced on diet and weight
control besides good glycaemic control.
This study shows that vast majority of the patients with
diabetes mellitus had poor glycaemic control and their
blood pressure did not achieve target goals. In addition,
the under use of medications especially ACEIs and ARBs,
coupled with patients' unhealthy lifestyles and
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behaviours, placing them at high risk of cardiovascular
diseases. This sub-optimal management could be
related to the factors of patients, healthcare providers,
policies and the availability of certain medications.
Patient factors include difficulties in adherence to
prescribed regimens, inaccessibility to medical care,
financial barriers, lack of understanding about the
seriousness of uncontrolled diabetes mellitus and fear of
hypoglycemia30• For healthcare providers, the main
factor may be due to the nonadherence to clinical
recommendations among the primary healthcare
doctors. In addition, the non-availability of certain
antidiabetic and antihypertensive medications in the
health centres may restrict their choice of
pharmacological treatment in managing patients with
diabetes mellitus.
This study is limited by its cross sectional design.
However, it does provide some useful information about
the doctors' management of diabetes mellitus and its
concomitant cardiovascular risk factors in the health
centres. Primary care doctors should be encouraged to
adopt and promote practice guidelines in their everyday
practice and these guidelines should be made readily
accessible at the point of service. Continuing medical
education can be provided to improve doctors'
knowledge and attitudes on diabetic care. Regular
audits of medical records and clinical management of
primary care doctors by senior doctors or Family
Medicine Specialists are other strategies to ensure the
adherence of guidelines and achievement of optimal
management in patients with diabetes mellitus.
Conclusion
The management of diabetes mellitus and its concomitant
cardiovascular risk factors in Melaka Tengah District
health centres was sub-optimal to those recommended
by the current guidelines. Greater efforts in
disseminating information and guidelines and continuing
medical education will help to decrease the morbidity
and mortality of patients with diabetes mellitus.
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